Share Price and Basic Stock Data
Last Updated: January 19, 2026, 9:02 pm
| PEG Ratio | 14.37 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Hindustan Zinc Ltd, a leader in the non-ferrous metals sector, particularly zinc and zinc alloys, reported a price of ₹658 and a market capitalization of ₹2,77,899 Cr. The company’s revenue from operations has shown a notable upward trajectory, with annual sales increasing from ₹13,636 Cr in FY 2014 to ₹34,098 Cr in FY 2023. This growth reflects the company’s robust positioning in the market, backed by a diverse product portfolio and a strategic focus on operational efficiency. However, the latest figures for FY 2024 indicate a decline in sales to ₹28,934 Cr, which can be attributed to fluctuating demand and potential macroeconomic challenges. Quarterly sales figures also depict a volatile trend, with the most recent quarter ending September 2023 recording sales of ₹6,792 Cr. Overall, while the revenue growth has been commendable, the recent dip raises questions about sustainability in a competitive landscape.
Profitability and Efficiency Metrics
Hindustan Zinc’s profitability metrics reflect a strong operational performance, evidenced by a reported operating profit margin (OPM) of 52% and a return on equity (ROE) of 72.4%. The company recorded a net profit of ₹10,459 Cr for FY 2025, showcasing its ability to convert sales into substantial earnings. The interest coverage ratio stood at 16.78x, indicating a comfortable ability to meet interest obligations, while the cash conversion cycle was impressively low at just 1 day. These figures highlight the company’s operational efficiency and effective cost management strategies. However, the net profit margin of 30.37% for FY 2025 shows a slight decline from previous years, suggesting that rising costs or pricing pressures may impact future profitability. Overall, Hindustan Zinc remains a profitable entity, but it must navigate cost-related challenges to maintain its margins.
Balance Sheet Strength and Financial Ratios
Hindustan Zinc’s balance sheet displays a solid foundation, with total borrowings reported at ₹11,169 Cr, against reserves of ₹12,770 Cr. The company’s debt-to-equity ratio stood at 0.79, indicating a moderate leverage position that is manageable within its cash flow generation capabilities. The interest coverage ratio of 16.78x further supports the strength of the balance sheet, showcasing ample earnings to cover interest expenses. The company’s return on capital employed (ROCE) is particularly impressive at 60.7%, significantly above industry averages, suggesting efficient utilization of capital. However, the high price-to-book value ratio of 14.65x could indicate overvaluation compared to sector norms, potentially raising concerns among investors. Overall, while the financial ratios portray a strong balance sheet, the elevated market valuation requires careful scrutiny.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Hindustan Zinc reveals a significant promoter holding of 61.84%, which suggests strong control and commitment from the founding entities. The presence of institutional investors, with foreign institutional investors (FIIs) holding 1.32% and domestic institutional investors (DIIs) at 4.92%, indicates a level of confidence from professional investors, although these figures are relatively low compared to industry peers. The total number of shareholders has increased to 7,99,768, reflecting growing retail interest, which is a positive sign for future liquidity. However, the decline in promoter holding from 64.92% in December 2022 to the current level may raise concerns regarding insider confidence in the company’s future. Overall, while the shareholding structure is robust, the trends warrant monitoring to maintain investor confidence.
Outlook, Risks, and Final Insight
Looking ahead, Hindustan Zinc’s prospects remain promising due to its strong market position and efficient operations; however, several risks could impact its performance. The declining sales figures and net profit margins suggest potential challenges in maintaining momentum. Additionally, fluctuations in zinc prices and macroeconomic conditions pose risks to revenue stability. The company’s high leverage, while currently manageable, could become a concern if interest rates rise significantly. On the other hand, strengths such as high ROE, robust cash flows, and a strong operational framework provide a solid foundation for future growth. Investors should weigh these strengths against the aforementioned risks, as well as the potential for further market fluctuations, to gauge Hindustan Zinc’s investment viability in the coming periods.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Zinc Ltd | 2,79,215 Cr. | 660 | 671/378 | 23.9 | 32.2 | 4.39 % | 60.7 % | 72.4 % | 2.00 |
| Industry Average | 279,215.00 Cr | 660.00 | 23.90 | 32.20 | 4.39% | 60.70% | 72.40% | 2.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8,336 | 7,866 | 8,509 | 7,282 | 6,792 | 7,310 | 7,550 | 8,130 | 8,242 | 8,556 | 9,041 | 7,723 | 8,525 |
| Expenses | 3,928 | 4,159 | 4,250 | 3,934 | 3,653 | 3,790 | 3,896 | 4,179 | 4,138 | 4,098 | 4,258 | 3,907 | 4,099 |
| Operating Profit | 4,408 | 3,707 | 4,259 | 3,348 | 3,139 | 3,520 | 3,654 | 3,951 | 4,104 | 4,458 | 4,783 | 3,816 | 4,426 |
| OPM % | 53% | 47% | 50% | 46% | 46% | 48% | 48% | 49% | 50% | 52% | 53% | 49% | 52% |
| Other Income | 367 | 349 | 356 | 287 | 231 | 305 | 280 | 277 | 185 | 221 | 230 | 282 | 237 |
| Interest | 51 | 62 | 176 | 218 | 232 | 243 | 262 | 256 | 319 | 285 | 251 | 239 | 259 |
| Depreciation | 798 | 807 | 928 | 801 | 825 | 904 | 936 | 843 | 875 | 903 | 1,013 | 911 | 881 |
| Profit before tax | 3,926 | 3,187 | 3,511 | 2,616 | 2,313 | 2,678 | 2,736 | 3,129 | 3,095 | 3,491 | 3,749 | 2,948 | 3,523 |
| Tax % | 32% | 32% | 26% | 25% | 25% | 24% | 25% | 25% | 26% | 24% | 21% | 25% | 25% |
| Net Profit | 2,681 | 2,157 | 2,589 | 1,970 | 1,737 | 2,038 | 2,042 | 2,358 | 2,298 | 2,647 | 2,976 | 2,204 | 2,632 |
| EPS in Rs | 6.35 | 5.10 | 6.13 | 4.66 | 4.11 | 4.82 | 4.83 | 5.58 | 5.44 | 6.26 | 7.04 | 5.22 | 6.23 |
Last Updated: January 1, 2026, 10:46 am
Below is a detailed analysis of the quarterly data for Hindustan Zinc Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 8,525.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,723.00 Cr. (Jun 2025) to 8,525.00 Cr., marking an increase of 802.00 Cr..
- For Expenses, as of Sep 2025, the value is 4,099.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,907.00 Cr. (Jun 2025) to 4,099.00 Cr., marking an increase of 192.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 4,426.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,816.00 Cr. (Jun 2025) to 4,426.00 Cr., marking an increase of 610.00 Cr..
- For OPM %, as of Sep 2025, the value is 52.00%. The value appears strong and on an upward trend. It has increased from 49.00% (Jun 2025) to 52.00%, marking an increase of 3.00%.
- For Other Income, as of Sep 2025, the value is 237.00 Cr.. The value appears to be declining and may need further review. It has decreased from 282.00 Cr. (Jun 2025) to 237.00 Cr., marking a decrease of 45.00 Cr..
- For Interest, as of Sep 2025, the value is 259.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 239.00 Cr. (Jun 2025) to 259.00 Cr., marking an increase of 20.00 Cr..
- For Depreciation, as of Sep 2025, the value is 881.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 911.00 Cr. (Jun 2025) to 881.00 Cr., marking a decrease of 30.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 3,523.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,948.00 Cr. (Jun 2025) to 3,523.00 Cr., marking an increase of 575.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 25.00%.
- For Net Profit, as of Sep 2025, the value is 2,632.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,204.00 Cr. (Jun 2025) to 2,632.00 Cr., marking an increase of 428.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 6.23. The value appears strong and on an upward trend. It has increased from 5.22 (Jun 2025) to 6.23, marking an increase of 1.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:15 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13,636 | 14,788 | 14,181 | 17,273 | 22,082 | 21,118 | 18,561 | 22,629 | 29,440 | 34,098 | 28,934 | 33,969 | 33,845 |
| Expenses | 6,717 | 7,338 | 7,923 | 7,534 | 9,812 | 10,448 | 9,691 | 10,957 | 13,214 | 16,577 | 15,253 | 16,630 | 16,362 |
| Operating Profit | 6,919 | 7,450 | 6,258 | 9,739 | 12,270 | 10,670 | 8,870 | 11,672 | 16,226 | 17,521 | 13,681 | 17,339 | 17,483 |
| OPM % | 51% | 50% | 44% | 56% | 56% | 51% | 48% | 52% | 55% | 51% | 47% | 51% | 52% |
| Other Income | 1,881 | 2,788 | 3,127 | 2,474 | 1,956 | 1,782 | 1,911 | 1,819 | 1,082 | 1,373 | 1,083 | 870 | 970 |
| Interest | 45 | 24 | 17 | 202 | 246 | 113 | 112 | 386 | 290 | 333 | 955 | 1,111 | 1,034 |
| Depreciation | 785 | 644 | 745 | 1,811 | 1,483 | 1,883 | 2,279 | 2,531 | 2,917 | 3,264 | 3,466 | 3,634 | 3,708 |
| Profit before tax | 7,970 | 9,570 | 8,623 | 10,200 | 12,497 | 10,456 | 8,390 | 10,574 | 14,101 | 15,297 | 10,343 | 13,464 | 13,711 |
| Tax % | 13% | 15% | 5% | 18% | 26% | 24% | 19% | 25% | 32% | 31% | 25% | 24% | |
| Net Profit | 6,905 | 8,178 | 8,175 | 8,316 | 9,276 | 7,956 | 6,805 | 7,980 | 9,630 | 10,520 | 7,787 | 10,279 | 10,459 |
| EPS in Rs | 16.34 | 19.35 | 19.35 | 19.68 | 21.95 | 18.83 | 16.11 | 18.89 | 22.79 | 24.90 | 18.43 | 24.33 | 24.75 |
| Dividend Payout % | 21% | 23% | 144% | 149% | 36% | 106% | 102% | 113% | 79% | 303% | 71% | 119% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 18.44% | -0.04% | 1.72% | 11.54% | -14.23% | -14.47% | 17.27% | 20.68% | 9.24% | -25.98% | 32.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -18.47% | 1.76% | 9.82% | -25.77% | -0.24% | 31.73% | 3.41% | -11.43% | -35.22% | 57.98% |
Hindustan Zinc Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 13% |
| 3 Years: | 5% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 9% |
| 3 Years: | 3% |
| TTM: | 25% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 15% |
| 3 Years: | 15% |
| 1 Year: | -12% |
| Return on Equity | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 38% |
| 3 Years: | 55% |
| Last Year: | 72% |
Last Updated: September 5, 2025, 6:20 am
Balance Sheet
Last Updated: December 4, 2025, 1:22 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 |
| Reserves | 36,573 | 42,508 | 36,540 | 29,960 | 35,087 | 32,760 | 39,465 | 31,468 | 33,437 | 12,097 | 14,388 | 12,445 | 12,770 |
| Borrowings | 0 | 0 | 0 | 7,908 | 0 | 2,538 | 611 | 7,201 | 2,844 | 11,881 | 8,722 | 10,964 | 11,169 |
| Other Liabilities | 4,259 | 5,639 | 15,810 | 13,082 | 7,000 | 6,315 | 6,054 | 6,213 | 7,545 | 10,631 | 9,949 | 10,164 | 10,690 |
| Total Liabilities | 41,677 | 48,992 | 53,195 | 51,795 | 42,932 | 42,458 | 46,975 | 45,727 | 44,671 | 35,454 | 33,904 | 34,418 | 35,474 |
| Fixed Assets | 9,147 | 9,446 | 10,385 | 9,993 | 11,302 | 14,778 | 16,469 | 16,808 | 17,396 | 17,620 | 18,055 | 18,488 | 19,147 |
| CWIP | 1,541 | 2,005 | 2,428 | 3,071 | 3,220 | 2,254 | 2,489 | 1,922 | 2,075 | 2,107 | 1,529 | 2,552 | 2,942 |
| Investments | 22,506 | 27,254 | 35,221 | 23,783 | 20,222 | 19,488 | 20,329 | 12,957 | 15,052 | 10,107 | 10,452 | 9,971 | 8,708 |
| Other Assets | 8,482 | 10,288 | 5,161 | 14,948 | 8,188 | 5,938 | 7,688 | 14,040 | 10,148 | 5,620 | 3,868 | 3,407 | 4,677 |
| Total Assets | 41,677 | 48,992 | 53,195 | 51,795 | 42,932 | 42,458 | 46,975 | 45,727 | 44,671 | 35,454 | 33,904 | 34,418 | 35,474 |
Below is a detailed analysis of the balance sheet data for Hindustan Zinc Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 845.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 845.00 Cr..
- For Reserves, as of Sep 2025, the value is 12,770.00 Cr.. The value appears strong and on an upward trend. It has increased from 12,445.00 Cr. (Mar 2025) to 12,770.00 Cr., marking an increase of 325.00 Cr..
- For Borrowings, as of Sep 2025, the value is 11,169.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 10,964.00 Cr. (Mar 2025) to 11,169.00 Cr., marking an increase of 205.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 10,690.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10,164.00 Cr. (Mar 2025) to 10,690.00 Cr., marking an increase of 526.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 35,474.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 34,418.00 Cr. (Mar 2025) to 35,474.00 Cr., marking an increase of 1,056.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 19,147.00 Cr.. The value appears strong and on an upward trend. It has increased from 18,488.00 Cr. (Mar 2025) to 19,147.00 Cr., marking an increase of 659.00 Cr..
- For CWIP, as of Sep 2025, the value is 2,942.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,552.00 Cr. (Mar 2025) to 2,942.00 Cr., marking an increase of 390.00 Cr..
- For Investments, as of Sep 2025, the value is 8,708.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9,971.00 Cr. (Mar 2025) to 8,708.00 Cr., marking a decrease of 1,263.00 Cr..
- For Other Assets, as of Sep 2025, the value is 4,677.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,407.00 Cr. (Mar 2025) to 4,677.00 Cr., marking an increase of 1,270.00 Cr..
- For Total Assets, as of Sep 2025, the value is 35,474.00 Cr.. The value appears strong and on an upward trend. It has increased from 34,418.00 Cr. (Mar 2025) to 35,474.00 Cr., marking an increase of 1,056.00 Cr..
Notably, the Reserves (12,770.00 Cr.) exceed the Borrowings (11,169.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 6.00 | 7.00 | 6.00 | 2.00 | 12.00 | 8.00 | -603.00 | 4.00 | 14.00 | 6.00 | 5.00 | 7.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 16 | 3 | 3 | 3 | 3 | 7 | 7 | 9 | 4 | 2 | 1 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 11 | 16 | 3 | 3 | 3 | 3 | 7 | 7 | 9 | 4 | 2 | 1 |
| Working Capital Days | -1 | -14 | -347 | -375 | -67 | -98 | -56 | -91 | -36 | -148 | -103 | -95 |
| ROCE % | 20% | 25% | 20% | 26% | 33% | 28% | 22% | 26% | 37% | 50% | 46% | 61% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Tata Arbitrage Fund | 2,636,200 | 0.63 | 127.91 | 1,857,100 | 2025-12-15 01:24:56 | 41.95% |
| DSP Natural Resources and New Energy Fund | 1,516,403 | 5.01 | 73.58 | 548,291 | 2025-12-08 04:19:05 | 176.57% |
| Mirae Asset Arbitrage Fund | 725,200 | 0.92 | 35.19 | N/A | N/A | N/A |
| Baroda BNP Paribas Large and Mid Cap Fund | 600,000 | 1.67 | 29.11 | 450,000 | 2025-12-15 01:24:56 | 33.33% |
| UTI Multi Asset Allocation Fund | 524,454 | 0.39 | 25.45 | 431,303 | 2025-12-15 00:05:20 | 21.6% |
| DSP Quant Fund | 393,587 | 2.06 | 19.1 | N/A | N/A | N/A |
| UTI Arbitrage Fund | 314,825 | 0.14 | 15.28 | 349,125 | 2025-12-15 01:24:56 | -9.82% |
| ICICI Prudential Commodities Fund | 283,101 | 0.43 | 13.74 | N/A | N/A | N/A |
| ITI Mid Cap Fund | 269,822 | 1 | 13.09 | N/A | N/A | N/A |
| Bandhan Infrastructure Fund | 268,562 | 0.83 | 13.03 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 24.50 | 18.36 | 24.88 | 22.79 | 18.89 |
| Diluted EPS (Rs.) | 24.50 | 18.36 | 24.88 | 22.79 | 18.89 |
| Cash EPS (Rs.) | 33.12 | 26.57 | 32.60 | 29.69 | 24.88 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 31.54 | 35.96 | 30.61 | 81.14 | 76.48 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 31.54 | 35.96 | 30.61 | 81.14 | 76.48 |
| Revenue From Operations / Share (Rs.) | 80.67 | 68.48 | 80.71 | 69.68 | 53.56 |
| PBDIT / Share (Rs.) | 43.48 | 34.86 | 44.70 | 41.28 | 31.93 |
| PBIT / Share (Rs.) | 34.87 | 26.66 | 36.97 | 34.38 | 25.94 |
| PBT / Share (Rs.) | 32.08 | 24.40 | 36.18 | 33.37 | 25.03 |
| Net Profit / Share (Rs.) | 24.50 | 18.36 | 24.88 | 22.79 | 18.89 |
| NP After MI And SOA / Share (Rs.) | 24.50 | 18.36 | 24.88 | 22.79 | 18.89 |
| PBDIT Margin (%) | 53.90 | 50.91 | 55.38 | 59.24 | 59.61 |
| PBIT Margin (%) | 43.22 | 38.92 | 45.81 | 49.33 | 48.43 |
| PBT Margin (%) | 39.76 | 35.62 | 44.83 | 47.89 | 46.72 |
| Net Profit Margin (%) | 30.37 | 26.81 | 30.82 | 32.70 | 35.26 |
| NP After MI And SOA Margin (%) | 30.37 | 26.81 | 30.82 | 32.70 | 35.26 |
| Return on Networth / Equity (%) | 77.69 | 51.06 | 81.27 | 28.08 | 24.69 |
| Return on Capital Employeed (%) | 63.24 | 48.85 | 86.71 | 37.65 | 28.95 |
| Return On Assets (%) | 30.01 | 22.89 | 29.63 | 21.55 | 17.45 |
| Long Term Debt / Equity (X) | 0.44 | 0.27 | 0.11 | 0.06 | 0.13 |
| Total Debt / Equity (X) | 0.79 | 0.55 | 0.91 | 0.08 | 0.22 |
| Asset Turnover Ratio (%) | 0.99 | 0.83 | 0.85 | 0.00 | 0.00 |
| Current Ratio (X) | 1.04 | 1.16 | 0.84 | 3.94 | 3.12 |
| Quick Ratio (X) | 0.86 | 0.98 | 0.74 | 3.61 | 2.94 |
| Inventory Turnover Ratio (X) | 17.87 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 118.35 | 70.79 | 303.50 | 78.99 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 87.56 | 48.92 | 231.58 | 60.62 | 0.00 |
| Earning Retention Ratio (%) | -18.35 | 29.21 | -203.50 | 21.01 | 0.00 |
| Cash Earning Retention Ratio (%) | 12.44 | 51.08 | -131.58 | 39.38 | 0.00 |
| Interest Coverage Ratio (X) | 16.78 | 15.42 | 56.71 | 60.14 | 34.95 |
| Interest Coverage Ratio (Post Tax) (X) | 10.53 | 9.12 | 32.56 | 34.67 | 21.67 |
| Enterprise Value (Cr.) | 205669.00 | 131756.63 | 134390.50 | 127908.25 | 113083.00 |
| EV / Net Operating Revenue (X) | 6.03 | 4.55 | 3.94 | 4.34 | 5.00 |
| EV / EBITDA (X) | 11.20 | 8.94 | 7.12 | 7.33 | 8.38 |
| MarketCap / Net Operating Revenue (X) | 5.73 | 4.27 | 3.64 | 4.44 | 5.09 |
| Retention Ratios (%) | -18.35 | 29.20 | -203.50 | 21.00 | 0.00 |
| Price / BV (X) | 14.65 | 8.13 | 9.59 | 3.82 | 3.57 |
| Price / Net Operating Revenue (X) | 5.73 | 4.27 | 3.64 | 4.44 | 5.09 |
| EarningsYield | 0.05 | 0.06 | 0.08 | 0.07 | 0.06 |
After reviewing the key financial ratios for Hindustan Zinc Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 24.50. This value is within the healthy range. It has increased from 18.36 (Mar 24) to 24.50, marking an increase of 6.14.
- For Diluted EPS (Rs.), as of Mar 25, the value is 24.50. This value is within the healthy range. It has increased from 18.36 (Mar 24) to 24.50, marking an increase of 6.14.
- For Cash EPS (Rs.), as of Mar 25, the value is 33.12. This value is within the healthy range. It has increased from 26.57 (Mar 24) to 33.12, marking an increase of 6.55.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 31.54. It has decreased from 35.96 (Mar 24) to 31.54, marking a decrease of 4.42.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 31.54. It has decreased from 35.96 (Mar 24) to 31.54, marking a decrease of 4.42.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 80.67. It has increased from 68.48 (Mar 24) to 80.67, marking an increase of 12.19.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 43.48. This value is within the healthy range. It has increased from 34.86 (Mar 24) to 43.48, marking an increase of 8.62.
- For PBIT / Share (Rs.), as of Mar 25, the value is 34.87. This value is within the healthy range. It has increased from 26.66 (Mar 24) to 34.87, marking an increase of 8.21.
- For PBT / Share (Rs.), as of Mar 25, the value is 32.08. This value is within the healthy range. It has increased from 24.40 (Mar 24) to 32.08, marking an increase of 7.68.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 24.50. This value is within the healthy range. It has increased from 18.36 (Mar 24) to 24.50, marking an increase of 6.14.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 24.50. This value is within the healthy range. It has increased from 18.36 (Mar 24) to 24.50, marking an increase of 6.14.
- For PBDIT Margin (%), as of Mar 25, the value is 53.90. This value is within the healthy range. It has increased from 50.91 (Mar 24) to 53.90, marking an increase of 2.99.
- For PBIT Margin (%), as of Mar 25, the value is 43.22. This value exceeds the healthy maximum of 20. It has increased from 38.92 (Mar 24) to 43.22, marking an increase of 4.30.
- For PBT Margin (%), as of Mar 25, the value is 39.76. This value is within the healthy range. It has increased from 35.62 (Mar 24) to 39.76, marking an increase of 4.14.
- For Net Profit Margin (%), as of Mar 25, the value is 30.37. This value exceeds the healthy maximum of 10. It has increased from 26.81 (Mar 24) to 30.37, marking an increase of 3.56.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 30.37. This value exceeds the healthy maximum of 20. It has increased from 26.81 (Mar 24) to 30.37, marking an increase of 3.56.
- For Return on Networth / Equity (%), as of Mar 25, the value is 77.69. This value is within the healthy range. It has increased from 51.06 (Mar 24) to 77.69, marking an increase of 26.63.
- For Return on Capital Employeed (%), as of Mar 25, the value is 63.24. This value is within the healthy range. It has increased from 48.85 (Mar 24) to 63.24, marking an increase of 14.39.
- For Return On Assets (%), as of Mar 25, the value is 30.01. This value is within the healthy range. It has increased from 22.89 (Mar 24) to 30.01, marking an increase of 7.12.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.44. This value is within the healthy range. It has increased from 0.27 (Mar 24) to 0.44, marking an increase of 0.17.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.79. This value is within the healthy range. It has increased from 0.55 (Mar 24) to 0.79, marking an increase of 0.24.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.99. It has increased from 0.83 (Mar 24) to 0.99, marking an increase of 0.16.
- For Current Ratio (X), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 1.5. It has decreased from 1.16 (Mar 24) to 1.04, marking a decrease of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has decreased from 0.98 (Mar 24) to 0.86, marking a decrease of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 17.87. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 17.87, marking an increase of 17.87.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 118.35. This value exceeds the healthy maximum of 50. It has increased from 70.79 (Mar 24) to 118.35, marking an increase of 47.56.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 87.56. This value exceeds the healthy maximum of 50. It has increased from 48.92 (Mar 24) to 87.56, marking an increase of 38.64.
- For Earning Retention Ratio (%), as of Mar 25, the value is -18.35. This value is below the healthy minimum of 40. It has decreased from 29.21 (Mar 24) to -18.35, marking a decrease of 47.56.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 12.44. This value is below the healthy minimum of 40. It has decreased from 51.08 (Mar 24) to 12.44, marking a decrease of 38.64.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 16.78. This value is within the healthy range. It has increased from 15.42 (Mar 24) to 16.78, marking an increase of 1.36.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 10.53. This value is within the healthy range. It has increased from 9.12 (Mar 24) to 10.53, marking an increase of 1.41.
- For Enterprise Value (Cr.), as of Mar 25, the value is 205,669.00. It has increased from 131,756.63 (Mar 24) to 205,669.00, marking an increase of 73,912.37.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.03. This value exceeds the healthy maximum of 3. It has increased from 4.55 (Mar 24) to 6.03, marking an increase of 1.48.
- For EV / EBITDA (X), as of Mar 25, the value is 11.20. This value is within the healthy range. It has increased from 8.94 (Mar 24) to 11.20, marking an increase of 2.26.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.73. This value exceeds the healthy maximum of 3. It has increased from 4.27 (Mar 24) to 5.73, marking an increase of 1.46.
- For Retention Ratios (%), as of Mar 25, the value is -18.35. This value is below the healthy minimum of 30. It has decreased from 29.20 (Mar 24) to -18.35, marking a decrease of 47.55.
- For Price / BV (X), as of Mar 25, the value is 14.65. This value exceeds the healthy maximum of 3. It has increased from 8.13 (Mar 24) to 14.65, marking an increase of 6.52.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.73. This value exceeds the healthy maximum of 3. It has increased from 4.27 (Mar 24) to 5.73, marking an increase of 1.46.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Zinc Ltd:
- Net Profit Margin: 30.37%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 63.24% (Industry Average ROCE: 60.7%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 77.69% (Industry Average ROE: 72.4%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 10.53
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.86
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23.9 (Industry average Stock P/E: 23.9)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.79
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 30.37%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Metals - Non Ferrous - Zinc/Zinc Alloys - Products | Yashad Bhawan, Yashadgarh, Udaipur Rajasthan 313004 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Priya Agarwal Hebbar | Non Exe. Non Ind Chairperson |
| Mr. Arun Misra | WholeTime Director & CEO |
| Mr. Navin Agarwal | Non Executive Director |
| Mr. Akhilesh Joshi | Ind. Non-Executive Director |
| Mr. Kannan Ramamirtham | Ind. Non-Executive Director |
| Ms. Pallavi Joshi Bakhru | Ind. Non-Executive Director |
| Mr. Vivek Kumar Bajpai | Non Exe. & Nominee Director |
| Mrs. Nirupama Kotru | Non Exe. & Nominee Director |
| Mr. Dinesh Mahur | Non Exe. & Nominee Director |
FAQ
What is the intrinsic value of Hindustan Zinc Ltd?
Hindustan Zinc Ltd's intrinsic value (as of 20 January 2026) is ₹473.05 which is 28.33% lower the current market price of ₹660.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,79,215 Cr. market cap, FY2025-2026 high/low of ₹671/378, reserves of ₹12,770 Cr, and liabilities of ₹35,474 Cr.
What is the Market Cap of Hindustan Zinc Ltd?
The Market Cap of Hindustan Zinc Ltd is 2,79,215 Cr..
What is the current Stock Price of Hindustan Zinc Ltd as on 20 January 2026?
The current stock price of Hindustan Zinc Ltd as on 20 January 2026 is ₹660.
What is the High / Low of Hindustan Zinc Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindustan Zinc Ltd stocks is ₹671/378.
What is the Stock P/E of Hindustan Zinc Ltd?
The Stock P/E of Hindustan Zinc Ltd is 23.9.
What is the Book Value of Hindustan Zinc Ltd?
The Book Value of Hindustan Zinc Ltd is 32.2.
What is the Dividend Yield of Hindustan Zinc Ltd?
The Dividend Yield of Hindustan Zinc Ltd is 4.39 %.
What is the ROCE of Hindustan Zinc Ltd?
The ROCE of Hindustan Zinc Ltd is 60.7 %.
What is the ROE of Hindustan Zinc Ltd?
The ROE of Hindustan Zinc Ltd is 72.4 %.
What is the Face Value of Hindustan Zinc Ltd?
The Face Value of Hindustan Zinc Ltd is 2.00.